Bo Cao Selected Research

Podophyllotoxin (Condylox)

3/2015	CIP-36, a novel topoisomerase II-targeting agent, induces the apoptosis of multidrug-resistant cancer cells in vitro.
10/2014	Synthesis and evaluation of novel podophyllotoxin derivatives as potential antitumor agents.
10/2011	[Anti-MDR tumor mechanism of CIP-36, a podophyllotoxin derivative].
2/2010	A novel podophyllotoxin derivative (YB-1EPN) induces apoptosis and down-regulates express of P-glycoprotein in multidrug resistance cell line KBV200.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bo Cao Research Topics

Disease

52	Neoplasms (Cancer) 07/2022 - 11/2005
9	Stomach Neoplasms (Stomach Cancer) 05/2022 - 11/2017
9	Schizophrenia (Dementia Praecox) 01/2022 - 12/2015
8	Lung Neoplasms (Lung Cancer) 07/2022 - 01/2020
8	Inflammation (Inflammations) 10/2021 - 11/2017
7	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 08/2011
7	Bipolar Disorder (Manic Depressive Psychosis) 01/2020 - 01/2016
5	Breast Neoplasms (Breast Cancer) 06/2022 - 01/2016
5	Wounds and Injuries (Trauma) 04/2022 - 08/2009
5	Carcinogenesis 01/2021 - 08/2011
4	Major Depressive Disorder (Major Depressive Disorders) 01/2022 - 07/2016
4	Hypoxia (Hypoxemia) 01/2022 - 12/2015
4	Cognitive Dysfunction 01/2021 - 12/2015
4	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2019 - 02/2016
4	Colorectal Neoplasms (Colorectal Cancer) 01/2018 - 07/2008
3	Neoplasm Metastasis (Metastasis) 01/2021 - 02/2019
3	Colonic Neoplasms (Colon Cancer) 01/2021 - 12/2016
3	Mental Disorders (Mental Disorder) 01/2021 - 09/2017
3	Fibrosis (Cirrhosis) 01/2019 - 02/2016
2	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 07/2022 - 01/2018
2	Pain (Aches) 10/2021 - 01/2018
2	COVID-19 10/2021 - 01/2021
2	Acute Lung Injury 06/2021 - 07/2019
2	Stroke (Strokes) 01/2021 - 01/2019
2	Genomic Instability 01/2020 - 08/2017
2	Psychotic Disorders (Schizoaffective Disorder) 01/2019 - 01/2018
2	Leukemia 01/2018 - 03/2015
2	Hepatocellular Carcinoma (Hepatoma) 12/2017 - 10/2013
2	Infections 12/2017 - 06/2015
2	Hypertrophic Cicatrix (Hypertrophic Scar) 07/2009 - 01/2008
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 06/2022
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 06/2022
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2022
1	Spinal Cord Injuries (Spinal Cord Injury) 01/2022
1	Hemorrhage 01/2022
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2022
1	Spinal Fractures 01/2022

Drug/Important Bio-Agent (IBA)

15	Proteins (Proteins, Gene)FDA Link 06/2022 - 07/2008
13	Pharmaceutical PreparationsIBA 01/2022 - 10/2014
9	MicroRNAs (MicroRNA)IBA 01/2021 - 06/2014
6	Biomarkers (Surrogate Marker)IBA 01/2020 - 03/2016
5	Biological ProductsIBA 12/2021 - 06/2017
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 08/2009
4	Glucose (Dextrose)FDA LinkGeneric 12/2021 - 12/2020
4	Interleukin-6 (Interleukin 6)IBA 01/2021 - 02/2016
4	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 01/2008
4	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2019 - 01/2011
4	AndrogensIBA 09/2015 - 08/2011
4	Androgen Receptors (Androgen Receptor)IBA 09/2015 - 08/2011
4	Podophyllotoxin (Condylox)FDA LinkGeneric 03/2015 - 02/2010
3	xihuangIBA 07/2022 - 10/2020
3	Circular RNAIBA 01/2022 - 01/2021
3	Bleomycin (Blenoxane)FDA LinkGeneric 01/2019 - 02/2016
3	LigandsIBA 01/2019 - 03/2013
3	Interleukin-17 (Interleukin 17)IBA 04/2018 - 02/2016
3	enzalutamideIBA 03/2014 - 11/2013
2	anlotinibIBA 07/2022 - 01/2021
2	Analgesics (Analgesic Drugs)IBA 10/2021 - 08/2019
2	VaccinesIBA 10/2021 - 01/2021
2	Complement System Proteins (Complement)IBA 09/2021 - 01/2020
2	Antidepressive Agents (Antidepressants)IBA 01/2021 - 01/2018
2	Prostate-Specific Antigen (Semenogelase)IBA 01/2021 - 01/2014
2	Antipsychotic Agents (Antipsychotics)IBA 01/2020 - 01/2019
2	Collagen Type I (Type I Collagen)IBA 01/2019 - 05/2010
2	CytokinesIBA 01/2019 - 04/2018
2	Hormones (Hormone)IBA 01/2019 - 01/2016
2	Antineoplastic Agents (Antineoplastics)IBA 01/2018 - 03/2015
2	pseudolaric acid BIBA 11/2017 - 11/2012
2	Phosphorylcholine (Phosphocholine)IBA 10/2017 - 10/2016
2	Phospholipids (Phosphatides)FDA LinkGeneric 10/2017 - 10/2016
2	Protons (Proton)IBA 10/2017 - 10/2016
2	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2016 - 03/2015
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 07/2016 - 01/2016
2	CIP-36IBA 03/2015 - 10/2011
2	Tuberculin (PPD)IBA 01/2014 - 03/2013
2	Transcription Factors (Transcription Factor)IBA 11/2012 - 01/2011
2	ChromatinIBA 07/2009 - 01/2008
1	CurcuminIBA 06/2022
1	UMI-77IBA 06/2022
1	SolutionsIBA 04/2022
1	Phosphotransferases (Kinase)IBA 01/2022
1	SphingolipidsIBA 01/2022
1	Desvenlafaxine Succinate FDA Link 01/2022
1	4-toluenesulfonyl fluoride (TSF)IBA 01/2022
1	EnzymesIBA 01/2022
1	tyrosine receptor (receptor, tyrosine)IBA 01/2022
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2022
1	Angiogenesis InhibitorsIBA 01/2022
1	Risperidone (Risperdal Consta)FDA LinkGeneric 01/2022

Therapy/Procedure

19	Therapeutics 07/2022 - 08/2011
6	Drug Therapy (Chemotherapy) 01/2022 - 04/2009
5	Castration 09/2015 - 08/2011
4	Precision Medicine 04/2022 - 11/2017
3	Neoadjuvant Therapy 05/2022 - 01/2016
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 07/2022 - 10/2021
2	Gastrectomy 05/2022 - 01/2021
2	Length of Stay 01/2022 - 12/2019
2	Complementary Therapies (Alternative Medicine) 10/2020 - 10/2019
1	Heterotopic Transplantation 06/2022
1	Decompression 01/2022